Virtus LifeSci Biotech Clinical Trials ETF
14 hedge funds and large institutions have $2.81M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$480K | |
| 2 | -$42.6K | |
| 3 | -$21.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$20.3K |
| 5 |
Comerica Bank
Dallas,
Texas
|
-$6.26K |